LNAI — Lunai Bioworks Balance Sheet
0.000.00%
- $1.48m
- $0.76m
- $0.05m
Annual balance sheet for Lunai Bioworks, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9.17 | 1.87 | 0.22 | 0.481 | 1.71 |
| Net Total Receivables | — | — | 1.11 | 0 | — |
| Prepaid Expenses | |||||
| Total Current Assets | 9.57 | 2.57 | 2 | 1.05 | 2.04 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.74 | 1.42 | 1.75 | 1.2 | 0.12 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 84.6 | 58.3 | 163 | 8.23 | 9.94 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.45 | 11 | 30.3 | 29.2 | 18.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12 | 11.8 | 31.2 | 29.6 | 19 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 72.6 | 46.5 | 132 | -21.3 | -9.02 |
| Total Liabilities & Shareholders' Equity | 84.6 | 58.3 | 163 | 8.23 | 9.94 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |